Gross Sherilyn A, Zhu Xiongzeng, Bao Liming, Ryder John, Le Anh, Chen Yan, Wang Xiao Qin, Irons Richard D
Fudan-Cinpathogen Clinical and Molecular Research Center, Institutes of Biomedical Sciences, Fudan University, 130 Dong An Road, 200032, Shanghai, China.
Molecular Toxicology and Environmental Health Sciences Program, School of Pharmacy, University of Colorado Denver, Denver, CO, USA.
Int J Hematol. 2008 Sep;88(2):165-173. doi: 10.1007/s12185-008-0132-1. Epub 2008 Jul 23.
The frequency of subtypes of lymphoid neoplasms was determined in a prospective series of 831 patients presenting at 29 Shanghai hospitals over a 4-year period. Diagnosis and classification was established in a single laboratory according to the 2001 WHO classification system. The frequency of non-Hodgkin lymphoma was 87.6% (n = 728) and Hodgkin lymphoma was 12.4% (n = 103). The most prevalent NHL subtypes diagnosed using WHO criteria were diffuse large B cell lymphoma (DLBCL), precursor B lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Although a low incidence has been reported in some Asian populations, CLL/SLL was commonly encountered, indicating that chronic lymphoid neoplasms are not rare in Shanghai. Consistent with previous reports, our findings indicate a decrease in the frequency of follicular lymphoma and an increase in T cell neoplasms compared to the West. Precursor T lymphoblastic leukemia/lymphoma, anaplastic large T cell lymphoma, aggressive NK cell leukemia, angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma were prominent subtypes of T cell NHL.
在一项前瞻性研究中,对4年间在上海29家医院就诊的831例患者的淋巴系统肿瘤亚型频率进行了测定。诊断和分类在单一实验室依据2001年世界卫生组织(WHO)分类系统进行。非霍奇金淋巴瘤的频率为87.6%(n = 728),霍奇金淋巴瘤为12.4%(n = 103)。按照WHO标准诊断出的最常见的非霍奇金淋巴瘤亚型为弥漫性大B细胞淋巴瘤(DLBCL)、前体B淋巴细胞白血病/淋巴瘤以及慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)。尽管在一些亚洲人群中报告的发病率较低,但CLL/SLL在本研究中较为常见,这表明慢性淋巴细胞肿瘤在上海并不罕见。与先前报告一致,我们的研究结果表明,与西方相比,滤泡性淋巴瘤的频率有所下降,而T细胞肿瘤的频率有所上升。前体T淋巴细胞白血病/淋巴瘤、间变性大T细胞淋巴瘤、侵袭性NK细胞白血病、血管免疫母细胞性T细胞淋巴瘤以及外周T细胞淋巴瘤是非霍奇金淋巴瘤中突出的T细胞亚型。